MD2848G2 - Metodă de diagnostic diferenţial al hepatitei cronice virale C şi hepatitei cronice C asociate cu infecţie herpetică - Google Patents

Metodă de diagnostic diferenţial al hepatitei cronice virale C şi hepatitei cronice C asociate cu infecţie herpetică

Info

Publication number
MD2848G2
MD2848G2 MDA20050049A MD20050049A MD2848G2 MD 2848 G2 MD2848 G2 MD 2848G2 MD A20050049 A MDA20050049 A MD A20050049A MD 20050049 A MD20050049 A MD 20050049A MD 2848 G2 MD2848 G2 MD 2848G2
Authority
MD
Moldova
Prior art keywords
viral hepatitis
lymphocytes
amount
chronic viral
differential diagnosis
Prior art date
Application number
MDA20050049A
Other languages
English (en)
Russian (ru)
Other versions
MD2848F1 (ro
Inventor
Влада-Татьяна ДУМБРАВА
Адела ЦУРКАНУ
Юлианна ЛУПАШКО
Лучия АНДРИЕШ
Original Assignee
ДУМБРАВА Влада-Татиана
Адела ЦУРКАНУ
Юлианна ЛУПАШКО
Лучия АНДРИЕШ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ДУМБРАВА Влада-Татиана, Адела ЦУРКАНУ, Юлианна ЛУПАШКО, Лучия АНДРИЕШ filed Critical ДУМБРАВА Влада-Татиана
Priority to MDA20050049A priority Critical patent/MD2848G2/ro
Publication of MD2848F1 publication Critical patent/MD2848F1/ro
Publication of MD2848G2 publication Critical patent/MD2848G2/ro

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Invenţia se referă la medicină, şi anume la hepatologie, şi este destinată pentru monitorizarea tratamentului hepatitei virale C.Esenţa metodei constă în aceea că se determină subpopulaţiile limfocitelor CD8 şi CD4 şi în cazul în care cantitatea limfocitelor CD8 constituie 17…20%, iar cantitatea limfocitelor CD4 - 40…44%, şi indicele imunoregulator este mai mare sau egal cu 2,2, se stabileşte diagnosticul hepatitei cronice virale C; iar în cazul în care cantitatea limfocitelor CD8 constituie 14…17%, iar cantitatea limfocitelor CD4 - 19…22%, şi indicele imunoregulator este mai mic sau egal cu 1,3, se stabileşte diagnosticul hepatitei virale C asociate cu virusul herpesului simplu.
MDA20050049A 2005-02-22 2005-02-22 Metodă de diagnostic diferenţial al hepatitei cronice virale C şi hepatitei cronice C asociate cu infecţie herpetică MD2848G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20050049A MD2848G2 (ro) 2005-02-22 2005-02-22 Metodă de diagnostic diferenţial al hepatitei cronice virale C şi hepatitei cronice C asociate cu infecţie herpetică

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20050049A MD2848G2 (ro) 2005-02-22 2005-02-22 Metodă de diagnostic diferenţial al hepatitei cronice virale C şi hepatitei cronice C asociate cu infecţie herpetică

Publications (2)

Publication Number Publication Date
MD2848F1 MD2848F1 (ro) 2005-09-30
MD2848G2 true MD2848G2 (ro) 2006-05-31

Family

ID=35057539

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20050049A MD2848G2 (ro) 2005-02-22 2005-02-22 Metodă de diagnostic diferenţial al hepatitei cronice virale C şi hepatitei cronice C asociate cu infecţie herpetică

Country Status (1)

Country Link
MD (1) MD2848G2 (ro)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD219Z (ro) * 2010-03-05 2011-01-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de determinare a gradului de activitate a hepatitei cronice virale C
MD302Z (ro) * 2010-06-30 2011-07-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de diagnosticare a hepatitelor virale cronice B şi C
MD319Z (ro) * 2010-06-30 2011-08-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de diagnosticare a hepatitei virale cronice D şi hepatitei mixte B+C

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Е.М. Скрягина, М. Вольф, О.М. Залуцкая, Г.Л. Гуревич, З.В. Лавор, И.М. Лаптева. Диагностика вируса простого герпеса 1-го и 2-го типов методом полимеразной цепной реакции в бронхоальвеолярном смыве <http://www.med.by/dn03/A6 3.htm.>, găsit 21.01.2005 *
Рахманова А.Г. и др. Вирусные гепатиты. Кольцово, 2002, с. 23 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD219Z (ro) * 2010-03-05 2011-01-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de determinare a gradului de activitate a hepatitei cronice virale C
MD302Z (ro) * 2010-06-30 2011-07-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de diagnosticare a hepatitelor virale cronice B şi C
MD319Z (ro) * 2010-06-30 2011-08-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de diagnosticare a hepatitei virale cronice D şi hepatitei mixte B+C

Also Published As

Publication number Publication date
MD2848F1 (ro) 2005-09-30

Similar Documents

Publication Publication Date Title
Winston et al. Minor changes in calculated creatinine clearance and anion‐gap are associated with tenofovir disoproxil fumarate‐containing highly active antiretroviral therapy
Green et al. CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia
BRPI0512017A (pt) dosagem otimizada com anticorpos anti-cd4 para indução de toleráncia em primatas
AR049141A1 (es) Uso de imatinib para tratar trastornos hepaticos e infecciones virales
AR042530A1 (es) Vacuna que comprende particulas viroides del virus papiloma humano 16 y 18
MD2848G2 (ro) Metodă de diagnostic diferenţial al hepatitei cronice virale C şi hepatitei cronice C asociate cu infecţie herpetică
WO2009006618A3 (en) Herpes simplex virus mutant icp0 protein
Wang et al. Miliary tuberculosis after initiation of ibrutinib in chronic lymphocytic leukemia
Clerico et al. Post-transplant lymphoproliferative disease (PTLD) after allogeneic hematopoietic stem cell transplantation: biology and treatment options
Yu et al. Quality of life of patients after allogeneic hematopoietic stem cell transplantation with antihuman thymocyte globulin
WO2009146213A3 (en) Single nucleotide polymorphisms (snp) and association with resistance to immune tolerance induction
WO2008045017A3 (en) Sars and ebola inhibitors and use thereof, and methods for their discovery
Taklual et al. Effect of human pegivirus route of transmission on the genetic distribution of the virus: an institution based cross-sectional study
Kannan et al. Coagulopathy in dengue fever patients
Bashey et al. Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002)
Bernard et al. NK Cells in Protection from HIV Infection
Alam et al. Cytomegalovirus infection in children after bone marrow transplantation: risk factors, clinical aspects and outcomes
Fregni et al. High number of CD56 bright NK-cells and persistently low CD4+ T-cells in a hemophiliac HIV/HCV co-infected patient without opportunistic infections
Baldanti et al. Higher levels of HIV DNA in memory and naive CD4+ T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAART
Fujiwara et al. Frequent detection of immunoglobulin M anti‐herpes simplex viral antibody in patients with primary biliary cirrhosis
UA85377C2 (ru) Применение композиции, содержащей вирусоподобные частички hpv16 і hpv18 при приготовлении медикамента для профилактики инфекции и/или болезни, вызванной группой hpv онкогенных типов, способы индуцирования иммунной реакции, профилактики инфекции и/или болезни, профилактики в популяции субъектов инфекции вызванных одной или несколькими группами онкогенных типов hpv, вакцинная композиция, которая включает hpv16 і нр18
McMath Measles meningoencephalomyelitis
Zaunders Intersection of immune checkpoints and CD8+ T cell noncytolytic suppression of HIV-1 infection: putting on the brakes versus the nuclear option
Chu et al. Human leukocyte antigen-DR expression in peripheral blood mononuclear cells in patients with tuberculosis
AKAGI Herpes Zoster, Herpes Simplex

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees